A trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma is the deadliest form of skin cancer. Around 100,000 Americans are expected to be diagnosed ...

But all melanoma diagnoses aren’t created equal. Survival rates vary widely by race, as shown by research published in the Journal of the American Academy of Dermatology today (July 11).

Moderna and Merck have presented promising results from their phase 2b clinical trial that investigated a combination of a messenger RNA (mRNA) vaccine and a cancer drug for the treatment of melanoma.

The phase 3 NADINA trial showed impressive responses to neoadjuvant nivolumab plus ipilimumab relative to adjuvant nivolumab (the current best practice), revealing a new standard of care for ...

Medically reviewed by Marla Anderson, MD Diagnosing melanoma typically requires a physical exam and a biopsy. Imaging and laboratory tests may also be used. The specific tests used to evaluate an ...

An investigational mRNA vaccine used along with immunotherapy continues to show benefit for people with high-risk forms of the skin cancer melanoma, the drugmakers said Thursday.

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new ...

Black men at higher risk of dying from skin cancer, study finds Men with melanoma, particularly Black men, are more likely to die than women with melanoma, according to a new study published in ...

The DecisionDx®-Melanoma test offers a precise look at a patient’s unique tumor biology, and enables patients and their care providers to co-create a personalized care plan.